Results 91 to 100 of about 37,978 (301)

Establishing a pediatric prenatal visit at The Health Center (THC) in Plainfield, VT [PDF]

, 2018
The AAP has long recommended a prenatal visit as part of the continuum of well-child care. However, this visit is underutilized by new families. Most prenatal education focuses on labor and childbirth with little to no information about parenting and the
Price, Katherine
core   +1 more source

[Postpartum depression screening scales: a systematic review].

Revista gaucha de enfermagem, 2011
This study aims to conduct a systematic review of postpartum depression (PPD) screening scales in puerperal applied until 16 weeks after delivery among women above 15 years old. Articles were searched in 4 databases. The included articles should describe precisely the definition and the validation of the used instruments. Out of the 424 abstracts found,
Juliana Machado, Schardosim, Elizeth, Heldt   +1 more
openaire   +1 more source

Cannabinoids and drug–drug pharmacokinetic interactions: Deciphering the risks

British Journal of Clinical Pharmacology, EarlyView.
The relationship between cannabinoids and mental health has become a major focus of scientific inquiry and public discourse. Cannabinoids are diverse chemical compounds from the Cannabis species that have been explored for their therapeutic applications in treating chronic pain, psychiatric and neurological conditions, such as depression, schizophrenia,
Paraskevi Papakyriakopoulou, Georgia Valsami, Georgios Ismailos   +2 more
wiley   +1 more source

Zuranolone: A case study in (regulatory) rush to judgement?

British Journal of Clinical Pharmacology, EarlyView.
Abstract Sage, in collaboration with Biogen, submitted a new drug approval for zuranolone for postpartum depression (PPD) and major depressive disorder (MDD) in December 2022. In August 2023, the US Food and Drug Administration granted approval for PPD but denied approval for MDD.
Lisa Cosgrove, Milutin Kostic, Barbara Mintzes, Gianna D'Ambrozio, Allen Shaughnessy   +4 more
wiley   +1 more source

Management of Prenatal Depression [PDF]

, 2017
Depression affects many women during and after pregnancy. As many as 1 in 5 women will experience a depressive episode during their pregnancy, however, studies have shown that less than 20% of these women will discuss their symptoms with their healthcare
Thura, Soraiya
core   +1 more source

The myth of the metabolic baseline: sleep–wake cycles undermine a foundational assumption in organismal biology

Biological Reviews, EarlyView.
ABSTRACT Basal and standard metabolic rate (BMR and SMR) are cornerstones of physiological ecology and are assumed to be relatively fixed intrinsic properties of organisms that represent the minimum energy required to sustain life. However, this assumption is conceptually flawed. Many core maintenance processes underlying SMR are temporally partitioned
Helena Norman, Daphne Cortese, Amelia Munson, Jan Lindström, Shaun S. Killen   +4 more
wiley   +1 more source

Delivery as a traumatic event: prevalence, risk factors, screening & treatment [PDF]

, 2004
This review looks at the evidence for postnatal posttraumatic stress disorder (PTSD). Postnatal traumatic stress responses are divided into: appraisal of birth as traumatic, traumatic stress responses (severe symptoms of intrusions and avoidance that do
Ayers, S.
core  

Bidirectional Psychoneuroimmune Interactions in the Early Postpartum Period Influence Risk of Postpartum Depression [PDF]

, 2015
More than 500,000 U.S. women develop postpartum depression (PPD) annually. Although psychosocial risks are known, the underlying biology remains unclear.
Aagaard-Tillery, Albacar, Anderson, Anisman, Association, Beck, Bensimon, Besedovsky, Besedovsky, Binder, Bloch, Bloch, Boufidou, Chapwanya, Charmandari, Chaudron, Christiaens, Christian, Chrousos, Chrousos, Cohen, Corwin, Corwin, Corwin, Corwin, Costas, Cox, Dantzer, Dennis, Donna O. McCarthy, Elenkov, Elenkov, Elizabeth J. Corwin, Field, Figueira, Fredericks, Gavin, Glynn, Goshtasebi, Groer, Guilbaud, Guintivano, Hay, Hebisch, Hojilla, Kalantaridou, Kathleen Pajer, Kimmel, Le Donne, Maes, Maes, Mary Weber, Mastorakos, Miller, Miller, Miller, Miller, Mor, Nancy Lowe, Nilsen-Hamilton, Okun, Osborne, O’Keane, Pace, Pace, Pearson, Petrovsky, Petrovsky, Pruessner, Raison, Raison, Ruiz, Salamonsen, Shelton, Steptoe, Sudeshna Paul, Taraz, Teissedre, Tsigos, Vitoratos, Watkins, Wisner, Yang, Yim   +83 more
core   +2 more sources

Advancing Maternal Health with Long‐Acting Therapeutics: Priorities, Efficacy and Safety Considerations, and Emerging Technologies

Clinical Pharmacology &Therapeutics, EarlyView.
Maternal health remains a critical global concern, particularly in underserved populations and in low‐ and middle‐income countries where access to safe and effective therapeutics is limited. Despite the use of medications by most women during pregnancy, the exclusion of pregnant and lactating women from clinical trials has resulted in significant data ...
Rachel K. Scott, Sharon Nachman, Ethel D. Weld, Rachel Daley, Shakir Atoyebi, Robert Bies, Catriona Waitt, Adeniyi Olagunju   +7 more
wiley   +1 more source

Postpartum Depression Screening of Women Veterans in Alaska Quality Improvement Project [PDF]

, 2017
A Project Submitted in Partial Fulfillment of the Requirements for the Degree of MASTER OF SCIENCE in Nursing SciencePostpartum depression screening guidelines were updated by the American College of Obstetricians and Gynecologists and the United ...
Brown, Elizabeth L.
core